Given the essential role of BDNF downregulation in pre-clinical stages of AD [34, 87] and its links to anxiety-like behaviors [23], we examined BDNF mRNA levels to determine if its cortical expression is altered after generalized immunosuppression. This evidence concerns the gene BDNF and Alzheimer disease.